Copyright
©2012 Baishideng Publishing Group Co.
World J Hepatol. Jan 27, 2012; 4(1): 11-17
Published online Jan 27, 2012. doi: 10.4254/wjh.v4.i1.11
Published online Jan 27, 2012. doi: 10.4254/wjh.v4.i1.11
Table 2 Characteristics of the patients (F0-F3 vs F4), (F0-F2 vs F3-F4) and (F0-F1 vs F2-F4)
| F0-F3(n = 115) | F4(n = 27) | P value | F0-F2(n = 86) | F3-F4(n = 56) | P value | F0-F1(n = 61) | F2-F4(n = 81) | P value | |
| Age (yr) | 60 (19-78) | 62 (23-78) | NS | 60 (19-78) | 62 (23-78) | NS | 60 (19-78) | 62 (23-78) | NS |
| Gender (male/female) | 48/67 | 12/15 | NS | 31/55 | 29/37 | NS | 25/36 | 35/46 | NS |
| AST (IU/L) | 35 (14-195) | 50 (20-328) | < 0.001 | 32 (14-175) | 46 (20-328) | < 0.001 | 32 (14-104) | 42 (18-328) | < 0.001 |
| ALT (IU/L) | 38 (10-388) | 47 (10-310) | < 0.05 | 31.5 (10-388) | 48 (10-310) | < 0.01 | 31 (11-388) | 46 (10-310) | < 0.01 |
| γ-GTP (IU/L) | 25 ( 7-183) | 50 (12-259) | < 0.001 | 22 ( 7-183) | 42.5 (12-259) | < 0.0001 | 22 ( 8-183) | 36 ( 7-259) | < 0.01 |
| ALP (IU/L) | 207 ( 97-490) | 267 (133-556) | < 0.001 | 186 (97-465) | 275 (133-556) | < 0.0001 | 207 ( 97-465) | 258 (101-556) | < 0.001 |
| Total bilirubin (mg/dL) | 0.7 (0.1-1.6) | 0.7 (0.3-2.1) | NS | 0.7 (0.1-1.6) | 0.8 (0.3-2.1) | NS | 0.7 (0.1-1.6) | 0.7 (0.3-2.1) | NS |
| Albumin (g/dL) | 4.02 ± 0.31 | 3.70 ± 0.43 | < 0.001 | 4.03 ± 0.32 | 3.84 ± 0.37 | < 0.01 | 4.05 ± 0.31 | 3.89 ± 0.38 | < 0.01 |
| Hemoglobin (g/dL) | 13.5 ± 1.7 | 12.8 ± 2.0 | NS | 13.5 ± 1.8 | 13.3 ± 1.7 | NS | 13.7 ± 1.7 | 13.2 ± 1.8 | NS |
| Platelet (× 104/mm3) | 16.5 ± 5.3 | 13.2 ± 5.9 | < 0.001 | 17.2 ± 5.2 | 13.8 ± 5.5 | < 0.001 | 17.2 ± 4.8 | 14.9 ± 5.9 | < 0.05 |
| PT-INR | 1.03 ± 0.05 | 1.08 ± 0.06 | < 0.001 | 1.02 ± 0.05 | 1.07 ± 0.06 | < 0.001 | 1.02 ± 0.05 | 1.05 ± 0.08 | < 0.05 |
- Citation: Aizawa N, Enomoto H, Imanishi H, Saito M, Iwata Y, Tanaka H, Ikeda N, Sakai Y, Takashima T, Iwai T, Moriwaki EI, Shimomura S, Iijima H, Nakamura H, Nishiguchi S. Elevation of the glycated albumin to glycated hemoglobin ratio during the progression of hepatitis C virus related liver fibrosis. World J Hepatol 2012; 4(1): 11-17
- URL: https://www.wjgnet.com/1948-5182/full/v4/i1/11.htm
- DOI: https://dx.doi.org/10.4254/wjh.v4.i1.11